SH

San-Bao Hwang

AL Alteon: 11 patents #4 of 29Top 15%
CY Cytomed: 5 patents #5 of 19Top 30%
Merck: 5 patents #2,116 of 9,382Top 25%
PR Picower Institute For Medical Research: 4 patents #10 of 37Top 30%
GB Golden Biotechnology: 2 patents #6 of 16Top 40%
TU The Rockefeller University: 1 patents #330 of 698Top 50%
📍 Iowa City, IA: #17 of 834 inventorsTop 3%
🗺 Iowa: #451 of 15,303 inventorsTop 3%
Overall (All Time): #175,078 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
10406120 Methods and compositions for treating kidney disorders Sheng-Yung Liu 2019-09-10
8309611 Methods and compositions for treating lung cancer Sheng-Yung Liu, Wu-Che Wen 2012-11-13
8153167 Herbal medicine for osteoporosis and related conditions Priya Gupta, Shiau Chuen Cheah 2012-04-10
7022719 Preventing and reversing the formation of advance glycosylation endproducts Anthony Cerami, Peter C. Ulrich, Dilip Wagle, Sara Vasan, John J. Egan 2006-04-04
RE38330 Preventing and reversing advanced glycosylation endproducts Anthony Cerami, Peter C. Ulrich, Dilip Wagle, Sara Vasan, John J. Egan 2003-11-25
6440749 Method of treating certain indications associated with hyperglycemia Anthony Cerami, Peter C. Ulrich, Dilip Wagle, Sara Vasan, John J. Egan 2002-08-27
6380192 Triazine compounds and method of use therefor Dilip Wagle, Michael E. Lankin 2002-04-30
6294574 Compounds and methods for the treatment of inflammatory and immune disorders Xiong Cai, Sajjat Hussoin, David Killian, T. Y. Shen 2001-09-25
6060470 Triazine compounds and methods of use therefor Dilip Wagle, Michael E. Lankin 2000-05-09
6007865 Reversing the formation of advanced glycosylation endproducts Anthony Cerami, Peter C. Ulrich, Dilip Wagle, Sara Vasan, John J. Egan 1999-12-28
5932578 Triazine compounds and methods of use therefor Dilip Wagle, Michael E. Lankin 1999-08-03
5856323 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase Xiong Cai, Sajjat Hussoin, David Killian, T. Y. Shen 1999-01-05
5853703 Preventing and reversing the formation of advanced glycosylation endproducts Anthony Cerami, Peter C. Ulrich, Dilip Wagle, Sara Vasan, John J. Egan 1998-12-29
5661139 Bis-(2-aryl) hydrazones Michael E. Lankin, David H. Shih, Dilip Wagle 1997-08-26
5656261 Preventing and reversing advanced glycosylation endproducts Anthony Cerami, Peter C. Ulrich, Dilip Wagle, Sara Vasan, John J. Egan 1997-08-12
5648486 Compounds and methods for the treatment of inflammatory and immune disorders Xiong Cai, Sajjat Hussoin, David Killian, T. Y. Shen 1997-07-15
5514676 Amino-benzoic acids and derivatives, and methods of use Peter C. Ulrich, Anthony Cerami, Dilip Wagle, Michael E. Lankin, David H. Shih 1996-05-07
5434151 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase Xiong Cai, Sajjat Hussoin, David Killian, T. Y. Shen 1995-07-18
5358938 Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase Xiong Cai, Saijat Hussoin, David Killian, T. Y. Shen 1994-10-25
4704462 Substituted 2,3,3a,6-tetrahydro-6-oxobenzofuran derivative useful as PAF antagonist Michael N. Chang, Mitree M. Ponpipom, Robert L. Bugianesi 1987-11-03
4656190 Indene derivatives and their use as PAF-antagonists Tsung-Ying Shen, Shu S. Yang 1987-04-07
4595693 Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists Tesfaye Biftu, Thomas W. Doebber, Thomas R. Beattie, Tsung-Ying Shen, Robert Stevenson 1986-06-17
4540709 Method for treatment of diseases mediated by PAF using 5-allyl-2-(3,4-Dimethoxyphenyl)-3a,.alpha.-methoxy-3-methyl-2,3,3a,6-tet rahydro-6-oxobenzofuran Michael N. Chang 1985-09-10
4539332 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists Tesfaye Biftu, Thomas W. Doebber, Thomas R. Beattie, Tsung-Ying Shen 1985-09-03